Bispecific antibodies (bsAbs) are genetically engineered, recombinant antibodies that consist of two distinct binding domains (variable regions or complementarity-determining region surfaces) capable of binding two different antigens or two different epitopes of the same antigen.
Novotech Identifies Decentralized Clinical Trials Potential and Challenges for Accelerating Global…
Hong Kong - Novotech, the leading Asia P
Read more